Intended for healthcare professionals


Drug trial investigators asked to declare financial interests

BMJ 1999; 318 doi: (Published 27 March 1999) Cite this as: BMJ 1999;318:831
  1. Annabel Ferriman
  1. BMJ

    Doctors and scientists who take part in UK clinical trials of new drugs which may later be licensed in the United States will have to declare any financial interests under new regulations issued by the United States Food and Drug Administration (FDA).

    The Association of the British Pharmaceutical Industry (ABPI) has told its members, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription